Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology...
Q2 2026
Aug 11, 2026
Q1 2026
May 5, 2026
FY 2025
Mar 9, 2026
Q4 2025
Q3 2025
Nov 10, 2025
